Literature DB >> 10949589

Muscarinic M3 receptor subtype gene expression in the human heart.

I Hellgren1, A Mustafa, M Riazi, I Suliman, C Sylvén, A Adem.   

Abstract

The heart is an important target organ for cholinergic function. In this study, muscarinic receptor subtype(s) in the human heart were determined using reverse transcription-polymerase chain reaction. Our results demonstrated muscarinic receptor M2 and M3 subtype RNA in left/right atria/ventricles of donor hearts. Receptor autoradiography analysis using selective muscarinic ligands indicated an absence of M1 receptor subtype in the human heart. The level of muscarinic receptor binding in atria was two to three times greater than in ventricles. Our results suggest that muscarinic receptors in the human heart are of the M2 and M3 subtypes. This is the first report of M3 receptors in the human myocardium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949589     DOI: 10.1007/s000180050507

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 2.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.

Authors:  Meng-Ting Wang; Jun-Ting Liou; Chen Wei Lin; Chen-Liang Tsai; Yun-Han Wang; Yu-Juei Hsu; Jyun-Heng Lai
Journal:  JAMA Intern Med       Date:  2018-02-01       Impact factor: 21.873

4.  Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.

Authors:  Jordi Heijman; Dorit Kirchner; Franziska Kunze; Eva Maria Chrétien; Martina B Michel-Reher; Niels Voigt; Michael Knaut; Martin C Michel; Ursula Ravens; Dobromir Dobrev
Journal:  Int J Cardiol       Date:  2017-12-22       Impact factor: 4.164

5.  M3 muscarinic receptors mediate positive inotropic responses in mouse atria: a study with muscarinic receptor knockout mice.

Authors:  Takio Kitazawa; Koichi Asakawa; Tatsuro Nakamura; Hiroki Teraoka; Toshihiro Unno; Sei-Ichi Komori; Masahisa Yamada; Jürgen Wess
Journal:  J Pharmacol Exp Ther       Date:  2009-05-08       Impact factor: 4.030

6.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

7.  Effects of atropine on human cardiac beta 1- and/or beta 2-adrenoceptor stimulation.

Authors:  Heike Bruck; Anke Ulrich; Stefan Gerlach; Joachim Radke; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-21       Impact factor: 3.000

8.  In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.

Authors:  C Salcedo; S Davalillo; J Cabellos; C Lagunas; D Balsa; S Pérez-Del-Pulgar; M Ballarín; Ag Fernández
Journal:  Br J Pharmacol       Date:  2009-02-16       Impact factor: 8.739

9.  Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats.

Authors:  Klaus Pönicke; Ingrid Heinroth-Hoffmann; Otto-Erich Brodde
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Effects of fitness and age on the response to vagotonic atropine.

Authors:  Kichang Lee; Glen Picard; Stacy D Beske; Gyu-Sam Hwang; J Andrew Taylor
Journal:  Auton Neurosci       Date:  2008-03-05       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.